Podcast

Destigmatizing Urology: Dr. Espinosa discusses lifestyle changes

Author(s):

Urology Times staff

“I think that the audience should know that there is a movement going on,” says Geo Espinosa, ND.

In this episode, Urology Times® Assistant Editor Janelle Hart spoke with Geo Espinosa, ND. He discusses why clinicians and patients are reluctant to incorporate holistic medicine into their health management, and how he believes this will change in the future. Espinosa is a holistic clinician and clinical assistant professor of urology at NYU Langone Health in New York City, New York.

Related Videos
Justin Dubin, MD, answers a question during a video interview
Man talking with a doctor | Image Credit: © RFBSIP - stock.adobe.com
Related Content
Label change for testosterone: Implications for urologists, prescribers, and patients
April 9th 2025

Label change for testosterone: Implications for urologists, prescribers, and patients

Hannah Clarke
In February 2025, the FDA recommended a removal of the black box warning related to an increased risk of adverse cardiovascular outcomes for all testosterone products. This recommendation has important implications for urologists and the patients they treat.
Introducing Pearls & Perspectives, with Amy Pearlman, MD!
April 21st 2025

Introducing Pearls & Perspectives, with Amy Pearlman, MD!

Amy M. Pearlman, MD
Pearls & Perspectives, hosted by Amy Pearlman, MD, is the latest multimedia program from Urology Times.
FDA issues labeling changes for testosterone products following TRAVERSE, postmarket studies
March 3rd 2025

FDA issues labeling changes for testosterone products following TRAVERSE, postmarket studies

Hannah Clarke
The FDA is requiring a warning about increased blood pressure and is recommending that the black box warning related to the increased risk of adverse cardiovascular events be removed.
Episode 4 Video: Moving Toward a Patient-Centered Approach in NMIBC Management
March 3rd 2025

Episode 4 Video: Moving Toward a Patient-Centered Approach in NMIBC Management

Max Kates, MD Neal Shore, MD, FACS Katie S. Murray, DO, MS
Panelists discuss the impact of long-term care in patients with non–muscle-invasive bladder cancer (NMIBC), considering the unique needs of specific patient groups and highlighting advancements in NMIBC treatment that may support better care experiences for patients.
FDA market clearance sought for Separo sealing system for vasectomy
January 29th 2025

FDA market clearance sought for Separo sealing system for vasectomy

Matthew J. Mutter, MD
"The biggest thing that I took away from using the device is that it allowed me to do the procedure by myself, without an assistant," says Matthew J. Mutter, MD.
FDA clears chemiluminescence-based immunoassay for free testosterone
January 10th 2025

FDA clears chemiluminescence-based immunoassay for free testosterone

Hannah Clarke
The test can provide results in 48 minutes for diagnostic insights for conditions such as hypogonadism, impotence, polycystic ovarian syndrome, and other androgenital syndromes.
© 2025 MJH Life Sciences

All rights reserved.